Home LiteratureArticle Details
PMID: 15772102 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

On criteria for evaluating models of absolute risk.

Biostatistics (Oxford, England) ·Vol. 6 ·No. 2 ·2005-04-00 ·Pages 227-39

Gail MH, Pfeiffer RM

Abstract

Absolute risk is the probability that an individual who is free of a given disease at an initial age, a, will develop that disease in the subsequent interval (a, t]. Absolute risk is reduced by mortality from competing risks. Models of absolute risk that depend on covariates have been used to design intervention studies, to counsel patients regarding their risks of disease and to inform clinical decisions, such as whether or not to take tamoxifen to prevent breast cancer. Several general criteria have been used to evaluate models of absolute risk, including how well the model predicts the observed numbers of events in subsets of the population ("calibration"), and "discriminatory power," measured by the concordance statistic. In this paper we review some general criteria and develop specific loss function-based criteria for two applications, namely whether or not to screen a population to select subjects for further evaluation or treatment and whether or not to use a preventive intervention that has both beneficial and adverse effects. We find that high discriminatory power is much more crucial in the screening application than in the preventive intervention application. These examples indicate that the usefulness of a general criterion such as concordance depends on the application, and that using specific loss functions can lead to more appropriate assessments.

MeSH Terms
Antineoplastic Agents, Phytogenic/adverse effects,therapeutic use Breast Neoplasms/prevention & control Colonic Neoplasms/diagnosis Colonoscopy/standards Decision Making Female Humans Middle Aged Models, Biological Models, Statistical Risk Tamoxifen/adverse effects,therapeutic use
Chemicals
Antineoplastic Agents, Phytogenic Tamoxifen
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Gail Mitchell H
Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Executive Plaza South, EPS 8032, Bethesda, MD 20892-7244, USA. gailm@mail.nih.gov
Pfeiffer Ruth M
Article Info
Journal
Biostatistics (Oxford, England)
Abbr.
Biostatistics
ISSN
1465-4644
Published
2005-04-00
Pages
227-39
Language
English
Region
England
NLM ID
100897327
Subset
IM
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com